SLC7A5 serves as a prognostic factor of breast cancer and promotes cell proliferation through activating AKT/mTORC1 signaling pathway

BACKGROUND: The purpose of our research was to determine if the clinical, pathological, and prognostic functions of SLC7A5 are the same as those of other molecular breast cancer (BC) subgroups. METHODS: We used the Oncomine and The Cancer Genome Atlas (TCGA) online databases to examine the expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Wang, Wei, Wu, Xue, Ling, Sunkai, Ma, Yu, Huang, Peilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184433/
https://www.ncbi.nlm.nih.gov/pubmed/34164526
http://dx.doi.org/10.21037/atm-21-2247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184433/
https://www.ncbi.nlm.nih.gov/pubmed/34164526
http://dx.doi.org/10.21037/atm-21-2247

Ejemplares similares